Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome, Nat Genet, vol.39, pp.457-66, 2007. ,
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality, Cell, vol.69, pp.915-941, 1992. ,
Role for DNA methylation in genomic imprinting, Nature, vol.366, pp.362-367, 1993. ,
X-chromosome inactivation in mammals, Annu Rev Genet, vol.31, pp.571-610, 1997. ,
Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers, Cancer Res, vol.62, pp.2370-2377, 2002. ,
Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis, Proc Natl Acad Sci, vol.95, pp.11891-11897, 1998. ,
The H-cadherin (CDH13) gene is inactivated in human lung cancer, Hum Genet, vol.103, pp.96-101, 1998. ,
Frequent and histological typespecific inactivation of 14-3-3sigma in human lung cancers, Oncogene, vol.21, pp.2418-2442, 2002. ,
Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer, J Natl Cancer Inst, vol.92, pp.1511-1517, 2000. ,
Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3, Nat Genet, vol.25, pp.315-324, 2000. ,
Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation, Cell Death Differ, vol.10, pp.356-64, 2003. ,
Aberrant promoter methylation of multiple genes in non-small cell lung cancers, Cancer Res, vol.61, pp.249-55, 2001. ,
Aberrant DNA methylation of OLIG1, a novel prognostic factor in non-small cell lung cancer, Proc Natl Acad Sci, vol.4, pp.252-259, 2007. ,
Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer, Oncogene, vol.26, pp.2621-2655, 2007. ,
A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies, PLoS Med, vol.3, p.486, 2006. ,
Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer, Lung Cancer, vol.55, pp.205-218, 2007. ,
Elevated mRNA levels of DNA methyltransferase-1 as an independent prognostic factor in primary nonsmall cell lung cancer, Cancer, vol.107, pp.1042-1051, 2006. ,
DNMT3B polymorphisms and risk of primary lung cancer, Carcinogenesis, vol.26, pp.403-412, 2005. ,
The potential role of histone deacetylase inhibitors in the treatment of nonsmall-cell lung cancer, Crit Rev Oncol Hematol, vol.68, pp.29-36, 2008. ,
Histone deacetylase inhibitor NVP-LAQ824 sensitizes human nonsmall cell lung cancer to the cytotoxic effects of ionizing radiation, Anticancer Drugs, vol.18, pp.793-800, 2007. ,
SAHA, a HDAC inhibitor, has profound anti-growth activity against non-small cell lung cancer cells, Oncol Rep, vol.15, pp.187-91, 2006. ,
In vitro study of CI-994, a histone deacetylase inhibitor, in non-small cell lung cancer cell lines, Oncol Res, vol.15, pp.39-48, 2005. ,
New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer, J Hematol Oncol, vol.2, p.22, 2009. ,
The Swi/Snf family nucleosome-remodeling complexes and transcriptional control, Trends Genet, vol.16, pp.345-51, 2000. ,
Targeted knockout of BRG1 potentiates lung cancer development, Cancer Res, vol.68, pp.3689-96, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00350882
Genetic and epigenetic screening for gene alterations of the chromatinremodeling factor, SMARCA4/BRG1, in lung tumors, Genes Chromosomes Cancer, vol.41, pp.170-177, 2004. ,
Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering, Cancer Res, vol.60, pp.4894-906, 2000. ,
Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer, Epigenetics, vol.3, pp.64-72, 2008. ,
Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer, Clin Cancer Res, vol.10, pp.4314-4338, 2004. ,
Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis, Cancer Res, vol.63, pp.560-566, 2003. ,
Oncomirs-microRNAs with a role in cancer, Nat Rev Cancer, vol.6, pp.259-69, 2006. ,
MicroRNA signatures in human cancers, Nat Rev Cancer, vol.6, pp.857-66, 2006. ,
A microRNA expression signature of human solid tumors defines cancer gene targets, Proc Natl Acad Sci, vol.103, pp.2257-61, 2006. ,
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis, Cancer Cell, vol.9, pp.189-98, 2006. ,
Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival, Cancer Res, vol.64, pp.3753-3759, 2004. ,
RAS is regulated by the let-7 microRNA family, Cell, vol.120, pp.635-682, 2005. ,
The let-7 microR-NA represses cell proliferation pathways in human cells, Cancer Res, vol.67, pp.7713-7735, 2007. ,
Promoter methylation of genes in bronchial lavages: a marker for early diagnosis of primary and relapsing non-small cell lung cancer?, Lung Cancer, vol.50, pp.199-209, 2005. ,
DNA methylation markers and early recurrence in stage I lung cancer, N Engl J Med, vol.358, pp.1118-1146, 2008. ,
DNA methylation as a therapeutic target in cancer, Clin Cancer Res, vol.13, pp.1634-1641, 2007. ,
Evaluation of an inhibitor of DNA methylation, 5-aza-2'-deoxycytidine, for the treatment of lung cancer and the future role of gene therapy, Adv Exp Med Biol, vol.465, pp.433-479, 2000. ,
Global levels of histone modifications predict prognosis in different cancers, Am J Pathol, vol.174, pp.1619-1647, 2009. ,
Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer, Nat Genet, vol.37, pp.391-400, 2005. ,
Loss of histone H4K20 trimethylation occurs in preneoplasia and influences prognosis of non-small cell lung cancer, Clin Cancer Res, vol.14, pp.7237-7282, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00372185
A chromatin-wide transition to H4K20 monomethylation impairs genome integrity and programmed DNA rearrangements in the mouse, Genes Dev, vol.22, pp.2048-61, 2008. ,
New p53 related genes in human tumors: significant downregulation in colon and lung carcinomas, Oncol Rep, vol.16, pp.603-611, 2006. ,
Chromatin modifications and their function, Cell, vol.128, pp.693-705, 2007. ,
NAD + -dependent deacetylation of H4 lysine 16 by class III HDACs, Oncogene, vol.26, pp.5505-5525, 2007. ,
Mutations and deletions of the CBP gene in human lung cancer, Clin Cancer Res, vol.11, pp.512-521, 2005. ,
Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients, Int J Cancer, vol.112, pp.26-32, 2004. ,
Histone deacetylase 1 mRNA expression in lung cancer, Lung Cancer, vol.46, pp.171-179, 2004. ,
Molecular cytogenetic characterization of a metastatic lung sarcomatoid carcinoma: 9p23 neocentromere and 9p23-p24 amplification including JAK2 and JMJD2C, Cancer Genet Cytogenet, vol.167, pp.122-152, 2006. ,
Identification of Myc-associated protein with JmjC domain as a novel therapeutic target oncogene for lung cancer, Mol Cancer Ther, vol.6, pp.542-51, 2007. ,
Global histone modifications predict prognosis of resected non small-cell lung cancer, J Clin Oncol, vol.25, pp.4358-64, 2007. ,
Global histone modification patterns predict risk of prostate cancer recurrence, Nature, vol.435, pp.1262-1268, 2005. ,
A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer, Cancer Res, vol.62, pp.4992-4997, 2002. ,
A high-throughput and sensitive method to measure global DNA methylation: application in lung cancer, BMC Cancer, vol.8, p.222, 2008. ,
Hypomethylation of p53 in peripheral blood DNA is associated with the development of lung cancer, Cancer Epidemiol Biomarkers Prev, vol.10, pp.69-74, 2001. ,
DNA methylation patterns in lung carcinomas, Semin Cancer Biol, vol.19, pp.181-188, 2009. ,
Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis, Oncogene, vol.23, pp.8841-8847, 2004. ,
The epigenetic progenitor origin of human cancer, Nat Rev Genet, vol.7, pp.21-33, 2006. ,
Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers, Oncogene, vol.10, pp.1493-1502, 1995. ,
Methylation, mutation and cancer, Bioessays, vol.14, pp.33-39, 1992. ,
Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons, J Natl Cancer Inst, vol.92, pp.803-814, 2000. ,
Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smokingassociated lung cancers, Cancer Res, vol.61, pp.7110-7117, 2001. ,
Cytosine methylation determines hot spots of DNA damage in the human p53 gene, Proc Natl Acad Sci, vol.94, pp.3893-3901, 1997. ,
Ubiquitous and tenacious methylation of the CpG site in codon 248 of the p53 gene may explain its frequent appearance as a mutational hot spot in human cancer, Mol Cell Biol, vol.14, pp.4225-4257, 1994. ,
Mutator pathways unleashed by epigenetic silencing in human cancer, Mutagenesis, vol.22, pp.247-53, 2007. ,
Inactivation of the DNA repair gene O 6 -methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia, Cancer Res, vol.59, pp.793-800, 1999. ,
Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis, Cancer Res, vol.61, pp.4689-92, 2001. ,
Association of O 6 -methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender and smoking status, Ann Surg Oncol, vol.15, pp.3272-3279, 2008. ,
Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokers, Int J Cancer, vol.107, pp.612-618, 2003. ,
Predicting lung cancer by detecting aberrant promoter methylation in sputum, Cancer Res, vol.60, pp.5954-5962, 2000. ,
Exosomal microRNA: a diagnostic marker for lung cancer, Clin Lung Cancer, vol.10, pp.42-48, 2009. ,
Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative realtime RT-PCR, Clin Chem, vol.54, pp.1696-704, 2008. ,
MicroRNA signature predicts survival and relapse in lung cancer, Cancer Cell, vol.13, pp.48-57, 2008. ,
MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy, Cancer Res, vol.67, pp.11111-11117, 2007. ,
MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer, Oncogene, vol.27, pp.3845-55, 2008. ,
Silencing of microRNAs in vivo with 'antagomirs', Nature, vol.438, pp.685-694, 2005. ,
Relationships of microRNA expression in mouse lung with age and exposure to cigarette smoke and light, FASEB J, 2009. ,
A microRNA component of the p53 tumour suppressor network, Nature, vol.447, pp.1130-1134, 2007. ,
Genetic unmasking of an epigenetically silenced microRNA in human cancer cells, Cancer Res, vol.67, pp.1424-1433, 2007. ,
Reduced expression of Dicer associated with poor prognosis in lung cancer patients, Cancer Sci, vol.96, pp.111-116, 2005. ,
An expression meta-analysis of predicted microRNA targets identifies a diagnostic signature for lung cancer, BMC Med Genomics, vol.1, p.61, 2008. ,
Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma, J Clin Oncol, vol.27, pp.2030-2037, 2009. ,
Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer, Lung Cancer, vol.67, pp.170-176, 2010. ,
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases, Cell Res, vol.18, pp.997-1006, 2008. ,
EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines, Ann Oncol, vol.19, pp.1053-1062, 2008. ,
A polycistronic microR-NA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation, Cancer Res, vol.65, pp.9628-9660, 2005. ,
Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92, Oncogene, vol.26, pp.6099-105, 2007. ,
Transgenic overexpression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells, Dev Biol, vol.310, pp.442-53, 2007. ,
c-Myc-regulated microRNAs modulate E2F1 expression, Nature, vol.435, pp.839-882, 2005. ,
Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma, Oncogene, vol.20, pp.1678-87, 2001. ,
Prediction of mammalian microRNA targets, Cell, vol.115, pp.787-98, 2003. ,
Impaired microRNA processing enhances cellular transformation and tumorigenesis, Nat Genet, vol.39, pp.673-680, 2007. ,